Global Vaccine Delivery Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Devices;

Syringes, Jet Injectors, and Others

By Route of Administration;

Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination, and Others

By Distribution Channel;

Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, and Vaccination Centers

By End User;

Hospitals, Clinics, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn136896604 Published Date: May, 2025 Updated Date: June, 2025

Vaccine Delivery Devices Market Overview

Vaccine Delivery Devices Market (USD Million)

Vaccine Delivery Devices Market was valued at USD 3,870.35 million in the year 2024. The size of this market is expected to increase to USD 6,272.08 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.1%.


Global Vaccine Delivery Devices Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 7.1 %


Study Period2025 - 2031
Base Year2024
CAGR (%)7.1 %
Market Size (2024)USD 3,870.35 Million
Market Size (2031)USD 6,272.08 Million
Market ConcentrationMedium
Report Pages304
3,870.35
2024
6,272.08
2031

Major Players

  • BD (Becton, Dickinson and Company)
  • Gerresheimer AG
  • West Pharmaceutical Services Inc
  • SCHOTT AG
  • Pfizer Inc
  • Teleflex Incorporated
  • Gerresheimer AG
  • Schott AG
  • AptarGroup Inc
  • Vetter Pharma International GmbH

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Vaccine Delivery Devices Market

Fragmented - Highly competitive market without dominant players


The Vaccine Delivery Devices Market is expanding rapidly due to the increasing need for precise, painless, and reliable vaccine administration. As global immunization efforts accelerate. There is growing preference for devices that enhance comfort and dosage accuracy. Nearly 65% of healthcare professionals prioritize patient-friendly technologies in vaccine delivery.

Innovations in Safe and Smart Delivery Devices
Technological progress is leading to smarter and safer vaccine devices, including auto-disable syringes, microneedles, and controlled-release systems. These solutions help minimize errors and improve dosage precision. Around 40% of newly developed devices incorporate features that directly target user safety and error prevention, supporting wider clinical adoption.

Public Health Programs Fueling Market Growth
Public health organizations are increasingly integrating advanced delivery tools into mass immunization campaigns. These efforts have led to a 45% increase in the deployment of specialized delivery devices, reflecting the market’s essential role in high-volume vaccine distribution. Scalable, efficient tools are now vital to achieving immunization coverage goals.

Focus on Safety Standards and Regulatory Adherence
Patient safety and compliance with healthcare regulations are now central to product development in this market. Over 55% of demand centers around devices that meet stringent safety criteria and are designed for user convenience. Regulatory support and rising provider awareness are further reinforcing the adoption of technologically advanced vaccine devices.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Devices
    2. Market Snapshot, By Route of Administration
    3. Market Snapshot, By Distribution Channel
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Vaccine Delivery Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Public health initiatives
        2. Technological advancements in delivery
        3. Rising vaccine demand globally
        4. Increased funding for healthcare
      2. Restraints
        1. Regulatory challenges and approvals
        2. Distribution infrastructure limitations
        3. Vaccine hesitancy and misinformation
        4. Economic disparities impacting access
      3. Opportunities
        1. Expansion of immunization programs
        2. Growing focus on preventative healthcare
        3. Innovations in needle-free delivery
        4. Collaborations for global vaccine access
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Vaccine Delivery Devices Market, By Devices, 2021 - 2031 (USD Million)
      1. Syringes
      2. Jet Injectors
      3. Others
    2. Vaccine Delivery Devices Market, By Route of Administration, 2021 - 2031 (USD Million)
      1. Intradermal Vaccination
      2. Intramuscular Vaccination
      3. Subcutaneous Vaccination
      4. Others
    3. Vaccine Delivery Devices Market, By Distribution Channel, 2021 - 2031 (USD Million)

      1. Online Pharmacies

      2. Retail Pharmacies

      3. Hospital Pharmacies

      4. Vaccination Centers

    4. Vaccine Delivery Devices Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Clinics
      3. Others
    5. Vaccine Delivery Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. BD (Becton, Dickinson and Company)
      2. Gerresheimer AG
      3. West Pharmaceutical Services Inc
      4. SCHOTT AG
      5. Pfizer Inc
      6. Teleflex Incorporated
      7. Gerresheimer AG
      8. Schott AG
      9. AptarGroup Inc
      10. Vetter Pharma International GmbH
  7. Analyst Views
  8. Future Outlook of the Market